The effects of metabolic status on non‐alcoholic fatty liver disease‐related outcomes, beyond the presence of obesity
Alimentary Pharmacology & Therapeutics2018Vol. 48(11-12), pp. 1260–1270
Citations Over TimeTop 10% of 2018 papers
Javier Ampuero, R. Aller, Rocío Gallego‐Durán, Jesús M. Bañales, Javier Crespo, Carmelo García‐Monzón, María Jesús Pareja, Eduardo Vilar‐Gómez, Juan Caballería, Desamparados Escudero‐García, Judith Gómez‐Camarero, José Luís Calleja, Mercedes Alfaro Latorre, Agustı́n Albillos, Javier Salmerón, Patricia Aspichueta, Oreste Lo Iacono, Rubén Francés, Salvador Benlloch, Conrado Fernández‐Rodríguez, Javier García‐Samaniego, Pamela Estévez, Raúl J. Andrade, Juan Turnés, Manuel Romero‐Gómez, HEPAmet Registry
Abstract
Metabolic unhealthy status showed a greater impact on NASH, significant fibrosis, kidney dysfunction, and atherogenic profile than obesity. However, metabolically healthy obesity was not a full healthy condition. We should focus our messages especially on patients with adverse metabolic conditions.
Related Papers
- → Review article: is non‐alcoholic fatty liver disease a spectrum, or are steatosis and non‐alcoholic steatohepatitis distinct conditions?(2012)215 cited
- → Clustering Effects of Metabolic Factors and the Risk of Metabolic Syndrome(2018)10 cited
- → Prevalence and Gender-Related Characteristics of Metabolic Syndrome in Korean Community(2014)2 cited
- → The Risk of Carotid Plaque Instability in Patients with Metabolic Syndrome: It is Higher in Women with Hypertriglyceridemia(2021)
- → Manifestation of Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis in Different Dietary Mouse Models(2016)